SOD1 and metabolic dysfunction-associated steatotic liver disease: Our results showed that ACP supplementation significantly decreased the hepatic levels of MDA and increased the activities of SOD, CAT, and GSH-PX, indicating that ACP supplementation could alleviate the NAFLD through elevating antioxidant capacity.